company

VEAKROSSEN APOTEK AS

4276 VEAVÃ…GEN

Return on Equity
70,27 %
Current Ratio
1,16
Debt-to-Equity Ratio
2,74
Key figures (NOK)2022
Revenue2 160 000
Net Income130 000
Total Assets4 018 000
Total Equity185 000
Income (NOK)2022
Revenue2 160 000
Expenditure1 996 000
Operating Profit165 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax165 000
Tax35 000
Net Income130 000
Balance (NOK)2022
Total Fixed Assets167 000
Total Current Assets3 851 000
Total Assets4 018 000
Total Retained Equity124 000
Total Equity185 000
Total Long-Term Debt507 000
Total Current Debt3 326 000
Total Equity and Debt4 018 000
Cash flow (NOK)2022
Sales Income2 160 000
Other Income0
Revenue2 160 000
Cost of Goods Sold1 670 000
Salary Costs258 000
Depreciation2 000
Impairment0
Expenditure1 996 000
Operating Profit165 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income130 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures167 000
Total Tangible Assets167 000
Total Fiancial Fixed Assets0
Total Fixed Assets167 000
Stock1 118 000
Total Investments0
Cash, Bank1 954 000
Total Current Assets3 851 000
Total Assets4 018 000
Total Equity185 000
Short-Term Group Debt0
Total Long-Term Debt507 000
Creditors2 959 000
Unpaid Taxes163 000
Dividends0
Other Current Debt176 000
Total Current Debt3 326 000
Total Equity and Debt4 018 000
Financial indicators2022
Return on Equity70,27 %
Debt-to-Equity Ratio2,74
Operating Profit Margin7,64 %
Current Ratio1,16
Quick Ratio1,74
Equity Ratio0,05
Gross Profit Margin22,69 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English